Abstract:Objective This meta-analysis attempted to derive pooled estimates for the associations between various cardiovascular-renal disorders and the deletion/insertion (D/I) polymorphism of the angiotensin converting enzyme (ACE) gene.Methods Case-control studies were combined, using the Mantel-Haenszel approach. Joint P values for continuous variables were calculated by Stouffer's method. Continuous measurements reported in different units were expressed on a percentage scale using the within-study mean of the II genotype as the denominator.Results The computerized database used for this analysis included 145 reports with an overall sample size of 49 959 subjects. Overall, possession of the D allele was associated with an increased risk of atherosclerotic and renal microvascular complications. In comparison with the II reference group, the excess risk in DD homozygotes (P < 0.001) was 32% for coronary heart disease (CHD; 30 studies), 45% for myocardial infarction (20 studies), 94% for stroke (five studies) and 56% for diabetic nephropathy (11 studies). The corresponding risk in DI heterozygotes amounted to 11% (P = 0.02), 13% (P = 0.02), 22% (P = 0.10) and 40% (P < 0.001), respectively. Hypertension (23 studies), left ventricular hypertrophy (five studies), hypertrophic or dilated cardiomyopathy (eight studies) and diabetic retinopathy (two studies) were not related to the DI polymorphism. Publication bias was observed for CHD, myocardial infarction and microvascular nephropathy, but not hypertension. In studies with DNA amplification in the presence of insertion-specific primers, the risk associated with the DD genotype increased to 150% [95% confidence interval (CI) 76-256; four studies] for diabetic nephropathy, but decreased to 12% (95% CI -3 to 28; seven studies) for CHD and 14% (95% CI -6 to 37; four studies) for myocardial infarction. On the other hand, the pooled odds ratios did not materially change if the metaanalysis was limited to articles published in journals with an impact factor of at least 4. Furthermore, compared with the II control group, the circulating ACE levels (29 studies) were raised 58 and 31% (P < 0.001) in DD and DI subjects, respectively. In contrast, plasma renin (10 studies), systolic and diastolic blood pressure (46 studies) and body mass index (30 studies) were not associated with the D allele.Conclusion The D allele is not associated with hypertension, but behaves as a marker of atherosclerotic cardiovascular complications and diabetic nephropathy. These associations do not necessarily imply a causal relationship and may have been inflated by publication bias. Nevertheless, their possible therapeutic implications may be subject to further investigation in prospective (intervention) studies. (C) Rapid Science Publishers ISSN 0263-6352.

Angiotensin-converting Enzyme Insertion/deletion Polymorphism Contributes to Ischemic Stroke Risk: a Meta-Analysis of 50 Case-Control Studies.

The Deletion/insertion Polymorphism of the Angiotensin Converting Enzyme Gene and Cardiovascular-Renal Risk.

Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with the Risk of Atherosclerosis.

Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with the Risk of Atherosclerosis

The Relationship Between Angiotensin Converting Enzyme Gene Polymorphism and Cerebral Stroke

The angiotensin converting enzyme insertion/deletion polymorphism and intracranial aneurysm: a meta-analysis of case-control studies.

Association of the Genetic Polymorphism of Angiotensin-Converting Enzyme and Idiopathic Dilated Cardiomyopathy

Association Between Angiotensin-Converting Enzyme Insertion/deletion Gene Polymorphism and End-Stage Renal Disease Susceptibility.

Angiotensin-converting Enzyme Gene Deletion Allele Increases the Risk of Left Ventricular Hypertrophy: Evidence from a Meta-Analysis

The ACE insertion/deletion polymorphism and its association with metabolic syndrome.

The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis

Association of ACE I/D Gene Polymorphism with Vascular Dementia: a Meta-Analysis.

Genetic Associations Of Angiotensin-Converting Enzyme With Primary Intracerebral Hemorrhage: A Meta-Analysis

Meta-analysis of angiotensin-converting enzyme insertion/deletion polymorphism and myocardial infarction in Han Chinese.

Impact Of Angiotensin I Converting Enzyme Insertion/Deletion Polymorphisms On Dilated Cardiomyopathy And Hypertrophic Cardiomyopathy Risk

Angiotensin converting enzyme D allele is associated with an increased risk of type 2 diabetes: evidence from a meta-analysis.

Meta-analysis of the association between the insertion/deletion polymorphism in ACE gene and coronary heart disease among the Chinese population.

Angiotensin-converting Enzyme Insertion/deletion Polymorphism is Not a Major Determining Factor in the Development of Sporadic Alzheimer Disease: Evidence from an Updated Meta-Analysis.

Relationship Between Angiotensin-Converting Enzyme Insertion/deletion Gene Polymorphism and Prostate Cancer Susceptibility.

Association Of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism With Panic Disorder Risk: A Meta-Analysis

Meta-analysis of the association between angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk.